• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA WHITE BLOOD CELL SET, CLOSED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT COBE SPECTRA BLOOD COLLECTION; COBE SPECTRA WHITE BLOOD CELL SET, CLOSED Back to Search Results
Catalog Number 70620
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Septic Shock (2068); Chills (2191)
Event Date 09/20/2015
Event Type  Injury  
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that during a stem cell collection procedure, the patient developed a fever and chills.He was transported to the emergency room and later was admitted to the icu and was given unknown medications.Approximately 15 hours after he was admitted to the icu, he developed septic shock symptoms.Per the customer, granulokine (filgrastim) was administered to the patient prior to the collection procedure.Patient information is not available at this time.The disposable kit is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: a bacterial culture was taken from the patient and test results were negative.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Per the therapeutic apheresis handbook: a physician's reference, 2nd edition, first time procedure patients reactions may occur in approximately 4.8% of procedures, and 1.2% of procedure patients experience reactions to citrate, based on the results of a survey of therapeutic procedures.Of these reactions, most were mild and well tolerated.The cobe spectra system has many safety features.A donor and/or patient reaction can occur rapidly, however.It is imperative that the operator continuously monitor the cobe spectra system and the donor and/or patient.Root cause: this disposable set was unavailable for specific root cause analysis.Based on information provided by the customer, it is possible that patient exhibited a reaction to acd-a and/or eto.
 
Event Description
The customer did not respond to attempts to obtain information for the investigation such as, procedural details and patient information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBE SPECTRA BLOOD COLLECTION
Type of Device
COBE SPECTRA WHITE BLOOD CELL SET, CLOSED
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
jessica kim
10810 w. collins ave
lakewood, CO 80215
3032314812
MDR Report Key5159999
MDR Text Key28674274
Report Number1722028-2015-00591
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
BK080035
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Followup
Report Date 09/24/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2017
Device Catalogue Number70620
Device Lot Number03Y15217
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/19/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/23/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-